# Cenntro Inc.: financial statements, quarterly

CENN · Nasdaq · CIK 1707919 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cenn.md) · [Financials](/companies/cenn/financials.md) · [Filings](/companies/cenn/filings.md) · [Insiders](/companies/cenn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cenn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5.8](/filings/0001140361-24-046046.md) | [(3.0) d](/filings/0001140361-25-011607.md) | [7.3](/filings/0001140361-25-030576.md) | [8.3](/filings/0001140361-24-036925.md) | [16.2](/filings/0001140361-25-041657.md) | [5.4 d](/filings/0001140361-26-014773.md) | [2.1](/filings/0001140361-26-021332.md) | [6.4](/filings/0001140361-26-033166.md) | [4.6](/filings/0001140361-25-041657.md) | [5.0 d](/filings/0001140361-26-014773.md) | [1.2](/filings/0001140361-26-021332.md) | [6.2](/filings/0001140361-26-033166.md) |
| Cost of revenue | $m | [5.0](/filings/0001140361-24-046046.md) | [(2.6) d](/filings/0001140361-25-011607.md) | [5.7](/filings/0001140361-25-030576.md) | [7.1](/filings/0001140361-24-036925.md) | [9.9](/filings/0001140361-25-041657.md) | [5.8 d](/filings/0001140361-26-014773.md) | [1.8](/filings/0001140361-26-021332.md) | [6.4](/filings/0001140361-26-033166.md) | [4.5](/filings/0001140361-25-041657.md) | [7.7 d](/filings/0001140361-26-014773.md) | [1.0](/filings/0001140361-26-021332.md) | [5.8](/filings/0001140361-26-033166.md) |
| Gross profit | $m | [0.7](/filings/0001140361-24-046046.md) | [(0.4) d](/filings/0001140361-25-011607.md) | [1.6](/filings/0001140361-25-030576.md) | [1.2](/filings/0001140361-24-036925.md) | [6.3](/filings/0001140361-25-041657.md) | [(0.4) d](/filings/0001140361-26-014773.md) | [0.3](/filings/0001140361-26-021332.md) | [(0.0)](/filings/0001140361-26-033166.md) | [0.1](/filings/0001140361-25-041657.md) | [(2.7) d](/filings/0001140361-26-014773.md) | [0.2](/filings/0001140361-26-021332.md) | [0.4](/filings/0001140361-26-033166.md) |
| Research and development | $m | [1.6](/filings/0001140361-24-046046.md) | [2.4 d](/filings/0001140361-25-011607.md) | [1.0](/filings/0001140361-25-030576.md) | [1.1](/filings/0001140361-24-036925.md) | [1.4](/filings/0001140361-25-041657.md) | [1.2 d](/filings/0001140361-26-014773.md) | [0.8](/filings/0001140361-26-021332.md) | [0.6](/filings/0001140361-26-033166.md) | [0.5](/filings/0001140361-25-041657.md) | [0.9 d](/filings/0001140361-26-014773.md) | [0.5](/filings/0001140361-26-021332.md) | [0.5](/filings/0001140361-26-033166.md) |
| Operating income | $m | [(12.6)](/filings/0001140361-24-046046.md) | [(7.0) d](/filings/0001140361-25-011607.md) | [(7.1)](/filings/0001140361-25-030576.md) | [(8.8)](/filings/0001140361-24-036925.md) | [(6.6)](/filings/0001140361-25-041657.md) | [(10.3) d](/filings/0001140361-26-014773.md) | [(6.2)](/filings/0001140361-26-021332.md) | [(8.1)](/filings/0001140361-26-033166.md) | [(6.9)](/filings/0001140361-25-041657.md) | [(11.4) d](/filings/0001140361-26-014773.md) | [(4.0)](/filings/0001140361-26-021332.md) | [(7.5)](/filings/0001140361-26-033166.md) |
| Interest expense | $m | [0.1](/filings/0001140361-24-046046.md) | [(0.5) d](/filings/0001140361-24-016853.md) | [(0.1)](/filings/0001140361-24-026231.md) | [0.1](/filings/0001140361-24-036925.md) | [0.0](/filings/0001140361-24-046046.md) | not reported | [0.2](/filings/0001140361-25-030576.md) | [0.1 d](/filings/0001140361-25-030576.md) | [0.1](/filings/0001140361-25-041657.md) | not reported | not reported | not reported |
| Income tax | $m | [(0.0)](/filings/0001140361-24-046046.md) | [(0.0) d](/filings/0001140361-25-011607.md) | [(0.0)](/filings/0001140361-25-030576.md) | [(0.0)](/filings/0001140361-24-036925.md) | [(0.0)](/filings/0001140361-25-041657.md) | [(0.0) d](/filings/0001140361-26-014773.md) | [(0.0)](/filings/0001140361-26-021332.md) | [(0.0)](/filings/0001140361-26-033166.md) | [(0.0)](/filings/0001140361-25-041657.md) | [(0.0) d](/filings/0001140361-26-014773.md) | [(0.0)](/filings/0001140361-26-021332.md) | [(0.1)](/filings/0001140361-26-033166.md) |
| Net income | $m | [(16.1)](/filings/0001140361-24-046046.md) | [(13.1) d](/filings/0001140361-25-011607.md) | [(9.2)](/filings/0001140361-25-030576.md) | [(9.2)](/filings/0001140361-24-036925.md) | [(9.0)](/filings/0001140361-25-041657.md) | [(17.5) d](/filings/0001140361-26-014773.md) | [(5.7)](/filings/0001140361-26-021332.md) | [(9.9)](/filings/0001140361-26-033166.md) | [(6.7)](/filings/0001140361-25-041657.md) | [(50.7) d](/filings/0001140361-26-014773.md) | [(3.9)](/filings/0001140361-26-021332.md) | [(10.6)](/filings/0001140361-26-033166.md) |
| Diluted EPS | $ per share | [(0.53)](/filings/0001140361-24-046046.md) | not reported | [(0.30)](/filings/0001140361-25-030576.md) | [(0.30)](/filings/0001140361-24-036925.md) | [(0.29)](/filings/0001140361-25-041657.md) | not reported | [(10.99)](/filings/0001140361-26-021332.md) | [(16.30)](/filings/0001140361-26-033166.md) | [(0.14)](/filings/0001140361-25-041657.md) | not reported | [(2.66)](/filings/0001140361-26-021332.md) | [(5.97)](/filings/0001140361-26-033166.md) |
| Basic EPS | $ per share | [(0.53)](/filings/0001140361-24-046046.md) | not reported | [(0.30)](/filings/0001140361-25-030576.md) | [(0.30)](/filings/0001140361-24-036925.md) | [(0.29)](/filings/0001140361-25-041657.md) | not reported | [(10.99)](/filings/0001140361-26-021332.md) | [(16.30)](/filings/0001140361-26-033166.md) | [(0.14)](/filings/0001140361-25-041657.md) | not reported | [(2.66)](/filings/0001140361-26-021332.md) | [(5.97)](/filings/0001140361-26-033166.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [44.6](/filings/0001140361-23-053309.md) | [28.8](/filings/0001140361-25-011607.md) | [20.2](/filings/0001140361-25-019312.md) | [16.0](/filings/0001140361-25-030576.md) | [22.4](/filings/0001140361-25-041657.md) | [12.5](/filings/0001140361-26-014773.md) | [8.5](/filings/0001140361-26-021332.md) | [6.0](/filings/0001140361-26-033166.md) | [4.4](/filings/0001140361-25-041657.md) | [4.5](/filings/0001140361-26-033166.md) | [3.6](/filings/0001140361-26-021332.md) | [4.3](/filings/0001140361-26-033166.md) |
| Current assets | $m | [110](/filings/0001140361-23-053309.md) | [105](/filings/0001140361-25-011607.md) | [94.7](/filings/0001140361-24-026231.md) | [91.6](/filings/0001140361-24-036925.md) | [84.8](/filings/0001140361-24-046046.md) | [65.9](/filings/0001140361-26-014773.md) | [62.9](/filings/0001140361-25-019312.md) | [58.6](/filings/0001140361-25-030576.md) | [52.3](/filings/0001140361-25-041657.md) | [45.6](/filings/0001140361-26-033166.md) | [45.0](/filings/0001140361-26-021332.md) | [41.6](/filings/0001140361-26-033166.md) |
| Total assets | $m | [192](/filings/0001140361-23-053309.md) | [186](/filings/0001140361-25-011607.md) | [173](/filings/0001140361-24-026231.md) | [168](/filings/0001140361-24-036925.md) | [160](/filings/0001140361-24-046046.md) | [133](/filings/0001140361-26-014773.md) | [129](/filings/0001140361-25-019312.md) | [124](/filings/0001140361-25-030576.md) | [113](/filings/0001140361-25-041657.md) | [74.4](/filings/0001140361-26-033166.md) | [73.3](/filings/0001140361-26-021332.md) | [68.4](/filings/0001140361-26-033166.md) |
| Current liabilities | $m | [26.2](/filings/0001140361-23-053309.md) | [29.3](/filings/0001140361-25-011607.md) | [27.2](/filings/0001140361-24-026231.md) | [30.9](/filings/0001140361-24-036925.md) | [31.4](/filings/0001140361-24-046046.md) | [29.1](/filings/0001140361-26-014773.md) | [31.0](/filings/0001140361-25-019312.md) | [32.6](/filings/0001140361-25-030576.md) | [27.4](/filings/0001140361-25-041657.md) | [26.7](/filings/0001140361-26-033166.md) | [26.6](/filings/0001140361-26-021332.md) | [25.2](/filings/0001140361-26-033166.md) |
| Total liabilities | $m | [59.9](/filings/0001140361-23-053309.md) | [63.7](/filings/0001140361-25-011607.md) | [60.5](/filings/0001140361-24-026231.md) | [63.7](/filings/0001140361-24-036925.md) | [63.0](/filings/0001140361-24-046046.md) | [54.6](/filings/0001140361-26-014773.md) | [55.9](/filings/0001140361-25-019312.md) | [44.7](/filings/0001140361-25-030576.md) | [36.6](/filings/0001140361-25-041657.md) | [34.0](/filings/0001140361-26-033166.md) | [35.6](/filings/0001140361-26-021332.md) | [34.4](/filings/0001140361-26-033166.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0001140361-25-011607.md) | not reported | [0.4](/filings/0001140361-24-036925.md) | [0.4](/filings/0001140361-24-046046.md) | [0.4](/filings/0001140361-26-014773.md) | [0.3](/filings/0001140361-25-019312.md) | [0.0](/filings/0001140361-25-030576.md) | [0.0](/filings/0001140361-25-041657.md) | [1.2](/filings/0001140361-26-033166.md) | [3.0](/filings/0001140361-26-021332.md) | [3.5](/filings/0001140361-26-033166.md) |
| Short-term borrowings | $m | not reported | [0.0](/filings/0001140361-25-011607.md) | not reported | not reported | [0.3](/filings/0001140361-24-046046.md) | [0.2](/filings/0001140361-26-014773.md) | [0.2](/filings/0001140361-25-019312.md) | [1.2](/filings/0001140361-25-030576.md) | [0.9](/filings/0001140361-25-041657.md) | [1.3](/filings/0001140361-26-033166.md) | [0.0](/filings/0001140361-26-021332.md) | [0.0](/filings/0001140361-26-033166.md) |
| Shareholders' equity | $m | [132](/filings/0001140361-23-053309.md) | [122](/filings/0001140361-25-011607.md) | [113](/filings/0001140361-24-026231.md) | [104](/filings/0001140361-24-036925.md) | [96.7](/filings/0001140361-24-046046.md) | [77.8](/filings/0001140361-26-014773.md) | [73.3](/filings/0001140361-25-019312.md) | [79.6](/filings/0001140361-25-030576.md) | [76.0](/filings/0001140361-25-041657.md) | [40.3](/filings/0001140361-26-033166.md) | [37.5](/filings/0001140361-26-021332.md) | [33.9](/filings/0001140361-26-033166.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(10.1) d](/filings/0001140361-24-046046.md) | [(12.9) d](/filings/0001140361-25-011607.md) | [(8.9)](/filings/0001140361-25-019312.md) | [(3.8) d](/filings/0001140361-25-030576.md) | [(0.2) d](/filings/0001140361-25-041657.md) | [(8.5) d](/filings/0001140361-26-014773.md) | [(5.0)](/filings/0001140361-26-021332.md) | [(4.4) d](/filings/0001140361-26-033166.md) | [(1.4) d](/filings/0001140361-25-041657.md) | [(1.8) d](/filings/0001140361-26-014773.md) | [(2.8)](/filings/0001140361-26-021332.md) | [(2.7) d](/filings/0001140361-26-033166.md) |
| Capital expenditure | $m | [2.2 d](/filings/0001140361-24-046046.md) | [0.3 d](/filings/0001140361-25-011607.md) | [0.3](/filings/0001140361-25-019312.md) | [0.3 d](/filings/0001140361-25-030576.md) | [0.1 d](/filings/0001140361-25-041657.md) | [0.1 d](/filings/0001140361-25-011607.md) | [0.5](/filings/0001140361-26-021332.md) | [0.1 d](/filings/0001140361-26-033166.md) | [0.1 d](/filings/0001140361-25-041657.md) | not reported | [0.0](/filings/0001140361-26-021332.md) | [0.1 d](/filings/0001140361-26-033166.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [30.3](/filings/0001140361-24-026231.md) | [30.4](/filings/0001140361-24-036925.md) | [30.4](/filings/0001140361-24-046046.md) | [30.8](/filings/0001140361-25-030576.md) | [30.8](/filings/0001140361-24-036925.md) | [30.8](/filings/0001140361-25-041657.md) | [0.5](/filings/0001140361-26-021332.md) | [0.6](/filings/0001140361-26-033166.md) | [51.2](/filings/0001140361-25-041657.md) | [1.5](/filings/0001140361-26-021332.md) | [1.8](/filings/0001140361-26-033166.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,456,452 at 2026-08-13, from the cover of the [10-Q filed 2026-08-14](/filings/0001140361-26-033166.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.